The Contribution of Decreased Muscle Size to Muscle Weakness in Children With Spastic Cerebral Palsy

Britta Hanssen, Nicky Peeters, Ines Vandekerckhove, Nathalie De Beukelaer, Lynn Bar-On, Guy Molenaers, Anja Van Campenhout, Marc Degelaen, Christine Van den Broeck, Patrick Calders, Kaat Desloovere, Britta Hanssen, Nicky Peeters, Ines Vandekerckhove, Nathalie De Beukelaer, Lynn Bar-On, Guy Molenaers, Anja Van Campenhout, Marc Degelaen, Christine Van den Broeck, Patrick Calders, Kaat Desloovere

Abstract

Muscle weakness is a common clinical symptom in children with spastic cerebral palsy (SCP). It is caused by impaired neural ability and altered intrinsic capacity of the muscles. To define the contribution of decreased muscle size to muscle weakness, two cohorts were recruited in this cross-sectional investigation: 53 children with SCP [median age, 8.2 (IQR, 4.1) years, 19/34 uni/bilateral] and 31 children with a typical development (TD) [median age, 9.7 (IQR, 2.9) years]. Muscle volume (MV) and muscle belly length for m. rectus femoris, semitendinosus, gastrocnemius medialis, and tibialis anterior were defined from three-dimensional freehand ultrasound acquisitions. A fixed dynamometer was used to assess maximal voluntary isometric contractions for knee extension, knee flexion, plantar flexion, and dorsiflexion from which maximal joint torque (MJT) was calculated. Selective motor control (SMC) was assessed on a 5-point scale for the children with SCP. First, the anthropometrics, strength, and muscle size parameters were compared between the cohorts. Significant differences for all muscle size and strength parameters were found (p ≤ 0.003), except for joint torque per MV for the plantar flexors. Secondly, the associations of anthropometrics, muscle size, gross motor function classification system (GMFCS) level, and SMC with MJT were investigated using univariate and stepwise multiple linear regressions. The associations of MJT with growth-related parameters like age, weight, and height appeared strongest in the TD cohort, whereas for the SCP cohort, these associations were accompanied by associations with SMC and GMFCS. The stepwise regression models resulted in ranges of explained variance in MJT from 29.3 to 66.3% in the TD cohort and from 16.8 to 60.1% in the SCP cohort. Finally, the MJT deficit observed in the SCP cohort was further investigated using the TD regression equations to estimate norm MJT based on height and potential MJT based on MV. From the total MJT deficit, 22.6-57.3% could be explained by deficits in MV. This investigation confirmed the disproportional decrease in muscle size and muscle strength around the knee and ankle joint in children with SCP, but also highlighted the large variability in the contribution of muscle size to muscle weakness.

Keywords: cerebral palsy; muscle size; muscle volume; muscle weakness; selective motor control; ultrasound.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Copyright © 2021 Hanssen, Peeters, Vandekerckhove, De Beukelaer, Bar-On, Molenaers, Van Campenhout, Degelaen, Van den Broeck, Calders and Desloovere.

Figures

Figure 1
Figure 1
Relationship between muscle volume and maximal joint torque for four lower limb joint movements in children with a typical development (TD) and with spastic cerebral palsy with gross motor function classification scale (GMFCS) levels I to III. (B) Regression formula parameters for the estimation of maximal joint torque based on muscle volume as shown in (A). SE, standardized error. The outliers indicate the cases that were removed based upon the standardized residuals or Cook's distance.
Figure 2
Figure 2
(A) Fictive example of the calculation of the different maximal joint torques (MJT) that were measured or estimated as a percentage of the expected score in typically developing children, their relative representation and their corresponding deficits. MJTpotential was based on muscle volume and the relationship with MJT in the typically developing cohort. The MJTnorm was based on the relationship of MJT with height in the typically developing cohort. The blue part indicates the relative MJTmeasured. The red part indicates the relative MJTdeficitMV, i.e., the deficit in strength that is proportional to the deficit in muscle volume. The orange part of the graph indicates the relative MJTdeficitother, representing the deficit in MJT that comes from other factors than the decrease in muscle volume. (B) Representation of the measured MJT and deficits relative to the expected score in typically developing children for four lower limb joint movements.

References

    1. Rosenbaum P, Paneth N, Leviton A, Goldstein M, Bax M, Damiano D, et al. . A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol. (2007) 49:8–14. 10.1111/j.1469-8749.2007.tb12610.x
    1. Surveillance of Cerebral Palsy in Europe . Prevalence and characteristics of children with cerebral palsy in Europe. Dev Med Child Neurol. (2002) 44:633–40. 10.1111/j.1469-8749.2002.tb00848.x
    1. Graham HK, Rosenbaum P, Paneth N, Dan B, Lin J-P, Damiano DL, et al. . Cerebral palsy. Nat Rev Dis Prim. (2016) 7:15082. 10.1038/nrdp.2016.5
    1. Wiley ME, Damiano DL. Lower-extremity strength profiles in spastic cerebral palsy. Dev Med Child Neurol. (1998) 40:100–7. 10.1111/j.1469-8749.1998.tb15369.x
    1. Goudriaan M, Nieuwenhuys A, Schless SH, Goemans N, Molenaers G, Desloovere K. A new strength assessment to evaluate the association between muscle weakness and gait pathology in children with cerebral palsy. PLoS ONE. (2018) 13:e0191097. 10.1371/journal.pone.0191097
    1. Elder GCB, Kirk J, Stewart G, Cook K, Weir D, Marshall A, et al. . Contributing factors to muscle weakness in children with cerebral palsy. Dev Med Child Neurol. (2003) 45:542–50. 10.1017/S0012162203000999
    1. Mockford M, Caulton JM. The pathophysiological basis of weakness in children with cerebral palsy. Pediatr Phys Ther. (2010) 22:222–33. 10.1097/PEP.0b013e3181dbaf96
    1. Edwards RHT. Physiological analysis of skeletal muscle weakness and fatigue. Clin Sci Mol Med. (1978) 54:463–70. 10.1042/cs0540463
    1. Desloovere K, Molenaers G, Feys H, Huenaerts C, Callewaert B, Walle P, Van de. Do dynamic and static clinical measurements correlate with gait analysis parameters in children with cerebral palsy? Gait Posture. (2006) 24:302–13. 10.1016/j.gaitpost.2005.10.008
    1. Ross SA, Engsberg JR. Relationships between spasticity, strength, gait, and the GMFM-66 in persons with spastic diplegia cerebral palsy. Arch Phys Med Rehabil. (2007) 88:1114–20. 10.1016/j.apmr.2007.06.011
    1. Kim WH, Park EY. Causal relation between spasticity, strength, gross motor function, and functional outcome in children with cerebral palsy: a path analysis. Dev Med Child Neurol. (2011) 53:68–73. 10.1111/j.1469-8749.2010.03777.x
    1. Noble JJ, Gough M, Shortland AP. Selective motor control and gross motor function in bilateral spastic cerebral palsy. Dev Med Child Neurol. (2019) 61:57–61. 10.1111/dmcn.14024
    1. Chruscikowski E, Fry NRD, Noble JJ, Gough M, Shortland AP. Selective motor control correlates with gait abnormality in children with cerebral palsy. Gait Posture. (2017) 52:107–9. 10.1016/j.gaitpost.2016.11.031
    1. Eek MN, Beckung E. Walking ability is related to muscle strength in children with cerebral palsy. Gait Posture. (2008) 28:366–71. 10.1016/j.gaitpost.2008.05.004
    1. Moreau NG. Muscle performance in children and youth with cerebral palsy: implications for resistance training. Cereb Palsy. (2020) 2629–40. 10.1007/978-3-319-74558-9_164
    1. Davids JR, Oeffinger DJ, Bagley AM, Sison-Williamson M, Gorton G. Relationship of strength, weight, age, and function in ambulatory children with cerebral palsy. J Pediatr Orthop. (2014) 35:523–9. 10.1097/BPO.0000000000000320
    1. Moreau NG, Simpson KN, Teefey SA, Damiano DL, Moreau NG. Muscle architecture predicts maximum strength and is related to activity levels in cerebral palsy. Phys Ther. (2010) 90:1619–30. 10.2522/ptj.20090377
    1. Hussain AW, Onambele GL, Williams AG, Morse CI. Muscle size, activation, and coactivation in adults with cerebral palsy. Muscle Nerve. (2014) 49:76–83. 10.1002/mus.23866
    1. Stackhouse SK, Binder-Macleod SA, Lee SCK. Voluntary muscle activation, contractile properties, and fatigability in children with and without cerebral palsy. Muscle Nerve. (2005) 31:594–601. 10.1002/mus.20302
    1. Reid SL, Pitcher CA, Williams SA, Licari MK, Valentine JP, Shipman PJ, et al. . Does muscle size matter? The relationship between muscle size and strength in children with cerebral palsy. Disabil Rehabil. (2015) 37:579–84. 10.3109/09638288.2014.935492
    1. Noble JJ, Charles-Edwards GD, Keevil SF, Lewis AP, Gough M, Shortland AP. Intramuscular fat in ambulant young adults with bilateral spastic cerebral palsy. BMC Musculoskelet Disord. (2014) 15:236. 10.1186/1471-2474-15-236
    1. Young HJ, Jenkins NT, Zhao Q, Mccully KK. Measurement of intramuscular fat by muscle echo intensity. Muscle and Nerve. (2015) 52:963–71. 10.1002/mus.24656
    1. Williams SA, Stott NS, Valentine J, Elliott C, Reid SL. Measuring skeletal muscle morphology and architecture with imaging modalities in children with cerebral palsy: a scoping review. Dev Med Child Neurol. (2020) 63:1–11. 10.1111/dmcn.14714
    1. Schless SH, Cenni F, Bar-On L, Hanssen B, Goudriaan M, Papageorgiou E, et al. . Combining muscle morphology and neuromotor symptoms to explain abnormal gait at the ankle joint level in cerebral palsy. Gait Posture. (2019) 68:531–7. 10.1016/j.gaitpost.2018.12.002
    1. Noble JJ, Fry NR, Lewis AP, Keevil SF, Gough M, Shortland AP. Lower limb muscle volumes in bilateral spastic cerebral palsy. Brain Dev. (2014) 36:294–300. 10.1016/j.braindev.2013.05.008
    1. Massaad A, Assi A, Bakouny Z, Bizdikian AJ, Skalli W, Ghanem I. Alterations of treatment-naïve pelvis and thigh muscle morphology in children with cerebral palsy. J Biomech. (2019) 82:178–85. 10.1016/j.jbiomech.2018.10.022
    1. Barber L, Hastings-Ison T, Baker R, Barrett R, Lichtwark G. Medial gastrocnemius muscle volume and fascicle length in children aged 2 to 5years with cerebral palsy. Dev Med Child Neurol. (2011) 53:543–8. 10.1111/j.1469-8749.2011.03913.x
    1. Handsfield GG, Meyer CH, Abel MF, Blemker SS. Heterogeneity of muscle sizes in the lower limbs of children with cerebral palsy. Muscle and Nerve. (2016) 53:933–45. 10.1002/mus.24972
    1. Barrett RS, Lichtwark GA. Gross muscle morphology and structure in spastic cerebral palsy: a systematic review. Dev Med Child Neurol. (2010) 52:794–804. 10.1111/j.1469-8749.2010.03686.x
    1. Moreau NG, Teefey SA, Damiano DL. In vivo muscle architecture and size of the rectus femoris and vastus lateralis in children and adolescents with cerebral palsy. Dev Med Child Neurol. (2010) 51:800–6. 10.1111/j.1469-8749.2009.03307.x
    1. Haberfehlner H, Jaspers RT, Rutz E, Becher JG, Harlaar J, van der Sluijs JA, et al. . Knee moment-angle characteristics and semitendinosus muscle morphology in children with spastic paresis selected for medial hamstring lengthening. PLoS ONE. (2016) 11:e0166401. 10.1371/journal.pone.0166401
    1. Schless S-H, Hanssen B, Cenni F, Bar-On L, Aertbelien E, Molenaers G, et al. . Estimating medial gastrocnemius muscle volume in children with spastic cerebral palsy: a cross-sectional investigation. Dmcn. (2017) 60:1–7. 10.1111/dmcn.13597
    1. Mohagheghi AA, Khan T, Meadows TH, Giannikas K, Baltzopoulos V, Maganaris CN. Differences in gastrocnemius muscle architecture between the paretic and non-paretic legs in children with hemiplegic cerebral palsy. Clin Biomech. (2007) 22:718–24. 10.1016/j.clinbiomech.2007.03.004
    1. Herskind A, Ritterband-Rosenbaum A, Willerslev-Olsen M, Lorentzen J, Hanson L, Lichtwark G, et al. . Muscle growth is reduced in 15-month-old children with cerebral palsy. Dev Med Child Neurol. (2016) 58:485–91. 10.1111/dmcn.12950
    1. Willerslev-Olsen M, Lund MC, Lorentzen J, Barber L, Kofoed-Hansen M, Nielsen JB. Impaired muscle growth precedes development of increased stiffness of the triceps surae musculotendinous unit in children with cerebral palsy. Dev Med Child Neurol. (2018) 60:672–9. 10.1111/dmcn.13729
    1. Shortland A. Muscle deficits in cerebral palsy and early loss of mobility: can we learn something from our elders? Dev Med Child Neurol. (2009) 51:59–63. 10.1111/j.1469-8749.2009.03434.x
    1. Ohata K, Tsuboyama T, Haruta T, Ichihashi N, Kato T, Nakamura T. Relation between muscle thickness, spasticity, and activity limitations in children and adolescents with cerebral palsy. Dev Med Child Neurol. (2008) 50:152–6. 10.1111/j.1469-8749.2007.02018.x
    1. Ohata K, Tsuboyama T, Haruta T, Ichihashi N, Nakamura T. Longitudinal change in muscle and fat thickness in children and adolescents with cerebral palsy. Dev Med Child Neurol. (2009) 51:943–8. 10.1111/j.1469-8749.2009.03342.x
    1. Choe YR, Kim JS, Kim KH, Yi TI. Relationship between functional level and muscle thickness in young children with cerebral palsy. Ann Rehabil Med. (2018) 42:286. 10.5535/arm.2018.42.2.286
    1. Akagi R, Takai Y, Ohta M, Kanehisa H, Kawakami Y, Fukunaga T. Muscle volume compared to cross-sectional area is more appropriate for evaluating muscle strength in young and elderly individuals. Age Ageing. (2009) 38:564–9. 10.1093/ageing/afp122
    1. Pitcher CA, Elliott CM, Williams SA, Licari MK, Kuenzel A, Shipman PJ, et al. . Childhood muscle morphology and strength: alterations over six months of growth. Muscle Nerve. (2012) 46:360–6. 10.1002/mus.23326
    1. Fukunaga T, Miyatani M, Tachi M, Kouzaki M, Kawakami Y. Muscle volume is a major determinant of joint torque in humans. Acta Physiol Scand. (2001) 172:249–55. 10.1046/j.1365-201x.2001.00867.x
    1. Franki I, Molenaers LBG, Campenhout A Van, Craenen K, Desloovere K, Feys H, et al. . Tone reduction and physical therapy: strengthening partners in treatment of children with spastic cerebral palsy. Neuropediatrics. (2020) 51:89–104. 10.1055/s-0039-3400987
    1. Walhain F, Desloovere K, Declerck M, Van Campenhout A, Bar-On L. Interventions and lower-limb macroscopic muscle morphology in children with spastic cerebral palsy: a scoping review. Dev Med Child Neurol. (2020) 63:1–13. 10.1111/dmcn.14652
    1. Palisano RJ, Rosenbaum P, Bartlett D, Livingston MH. Content validity of the expanded and revised Gross Motor Function Classification System. Dev Med Child Neurol. (2008) 50:744–50. 10.1111/j.1469-8749.2008.03089.x
    1. Bohannon RW, Smith MB. Inter rater reliability of a modified Ashworth Scale of muscle spasticity. Phys Ther. (1987) 67:206–7. 10.1093/ptj/67.2.206
    1. Boyd R. Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with cerebral palsy. Eur J Neurol. (1999) 6:1–13. 10.1111/j.1468-1331.1999.tb00031.x
    1. Matthews WB. Aids to the examination of the peripheral nervous system. J Neurol Sci. (1977) 33:299. 10.1016/0022-510X(77)90205-2
    1. Gage JR, Schwartz M, Koop S, Novacheck T. The Identification and Treatment of Gait Problems in Cerebral Palsy. London: Mac Keith Press; (2009). 187 p.
    1. Cenni F, Monari D, Desloovere K, Erwin A, Schless S, Bruyninckx H. The reliability and validity of a clinical 3D freehand ultrasound system. Comput Methods Programs Biomed. (2016) 136:179–87. 10.1016/j.cmpb.2016.09.001
    1. Cenni F, Schless S-H, Bar-On L, Molenaers G, Van Campenhout A, Aertbeliën E, et al. . Can in vivo medial gastrocnemius muscle–tendon unit lengths be reliably estimated by two ultrasonography methods? A within-session analysis. Ultrasound Med Biol. (2018) 44:110–8. 10.1016/j.ultrasmedbio.2017.09.018
    1. Barber L, Alexander C, Shipman P, Boyd R, Reid S, Elliott C. Validity and reliability of a freehand 3D ultrasound system for the determination of triceps surae muscle volume in children with cerebral palsy. J Anat. (2018) 234:384–91. 10.1111/joa.12927
    1. Hanssen B, De Beukelaer N, Schless S-H, Cenni F, Bar-On L, Peeters N, et al. . Reliability of processing 3-D freehand ultrasound data to define muscle volume and echo-intensity in pediatric lower limb muscles with typical development or with spasticity. Ultrasound Med Biol. (2021). 10.1016/j.ultrasmedbio.2021.04.028. [Epub ahead of print].
    1. Hinkle D, Wiersma W, Jurs S. Applied Statistics for the Behavioural Sciences. Boston, MA: Houghton Mifflin; (2003).
    1. O'Brien SM, Carroll TJ, Barber LA, Lichtwark GA. Plantar flexor voluntary activation capacity, strength and function in cerebral palsy. Eur J Appl Physiol. (2021). 10.1007/s00421-021-04638-z
    1. Obst SJ, Bickell R, Florance K, Boyd RN, Read F, Barber L. The size and echogenicity of the tibialis anterior muscle is preserved in both limbs in young children with unilateral spastic cerebral palsy. Disabil Rehabil. (2020) 43:1–10. 10.1080/09638288.2020.1863482
    1. Gillett JG, Lichtwark GA, Boyd RN, Barber LA. Functional capacity in adults with cerebral palsy: lower limb muscle strength matters. Arch Phys Med Rehabil. (2018) 99:900–6. 10.1016/j.apmr.2018.01.020
    1. Hastings-Ison T, Graham HK. Atrophy and hypertrophy following injections of botulinum toxin in children with cerebral palsy. Dev Med Child Neurol. (2013) 55:778–9. 10.1111/dmcn.12231
    1. Schless SH, Cenni F, Bar-On L, Hanssen B, Kalkman B, O'brien T, et al. . Medial gastrocnemius volume and echo-intensity after botulinum neurotoxin A interventions in children with spastic cerebral palsy. Dev Med Child Neurol. (2019) 61:783–90. 10.1111/dmcn.14056
    1. Belanger AY, Mccomas AJ. Extent of motor unit activiation during effort. J Appl. (1981) 51:1131–5. 10.1152/jappl.1981.51.5.1131
    1. Fowler EG, Staudt LA, Greenberg MB, Oppenheim WL. Selective Control Assessment of the Lower Extremity (SCALE): development, validation, and interrater reliability of a clinical tool for patients with cerebral palsy. Dev Med Child Neurol. (2009) 51:607–14. 10.1111/j.1469-8749.2008.03186.x
    1. Lieber RL, Friden J. Functional and clinical significance of skeletal muscle architecture. Muscle Nerve. (2000) 23:1647–66. 10.1002/1097-4598(200011)23:11<1647::AID-MUS1>;2-M
    1. Frisk RF, Lorentzen J, Barber L, Nielsen JB. Characterization of torque generating properties of ankle plantar flexor muscles in ambulant adults with cerebral palsy. Eur J Appl Physiol. (2019) 119:1127–36. 10.1007/s00421-019-04102-z
    1. Obst SJ, Boyd R, Read F, Barber L. Quantitative 3-D ultrasound of the medial gastrocnemius muscle in children with unilateral spastic cerebral palsy. Ultrasound Med Biol. (2017) 43:2814–23. 10.1016/j.ultrasmedbio.2017.08.929
    1. Jones EJ, Bishop PA, Woods AK, Green JM. Cross-sectional area and muscular strength: a brief review. Sport Med. (2008) 38:987–94. 10.2165/00007256-200838120-00003
    1. Gillett JG, Boyd RN, Carty CP, Barber LA. The impact of strength training on skeletal muscle morphology and architecture in children and adolescents with spastic cerebral palsy: a systematic review. Res Dev Disabil. (2016) 56:183–96. 10.1016/j.ridd.2016.06.003
    1. O'Brien SM, Lichtwark GA, Carroll TJ, Barber LA. Impact of lower limb active movement training in individuals with spastic type cerebral palsy on neuromuscular control outcomes: a systematic review. Front Neurol. (2020) 11:581892. 10.3389/fneur.2020.581892
    1. Clark BC. In vivo alterations in skeletal muscle form and function after disuse atrophy. Med Sci Sports Exerc. (2009) 41:1869–75. 10.1249/MSS.0b013e3181a645a6
    1. Rooks DS, Laurent D, Praestgaard J, Rasmussen S, Bartlett M, Tankó LB. Effect of bimagrumab on thigh muscle volume and composition in men with casting-induced atrophy. J Cachexia Sarcopenia Muscle. (2017) 8:727–34. 10.1002/jcsm.12205
    1. Gough M, Fairhurst C, Shortland a P. Botulinum toxin and cerebral palsy: time for reflection? Dev Med Child Neurol. (2005) 47:709–12. 10.1017/S0012162205001453
    1. Schroeder AS, Ertl-Wagner B, Britsch S, Schröder JM, Nikolin S, Weis J, et al. . Muscle biopsy substantiates long-term MRI alterations one year after a single dose of botulinum toxin injected into the lateral gastrocnemius muscle of healthy volunteers. Mov Disord. (2009) 24:1494–503. 10.1002/mds.22661
    1. Pingel J, Bartels EM, Nielsen JB. New perspectives on the development of muscle contractures following central motor lesions. J Physiol. (2017) 595:1027–38. 10.1113/JP272767
    1. Gough M, Shortland AP. Could muscle deformity in children with spastic cerebral palsy be related to an impairment of muscle growth and altered adaptation? Dev Med Child Neurol. (2012) 54:495–9. 10.1111/j.1469-8749.2012.04229.x
    1. Smith LR, Lee KS, Ward SR, Chambers HG, Lieber RL. Hamstring contractures in children with spastic cerebral palsy result from a stiffer extracellular matrix and increased in vivo sarcomere length. J Physiol. (2011) 589:2625–39. 10.1113/jphysiol.2010.203364
    1. Matthiasdottir S, Hahn M, Yaraskavitch M, Herzog W. Muscle and fascicle excursion in children with cerebral palsy. Clin Biomech. (2014) 29:458–62. 10.1016/j.clinbiomech.2014.01.002
    1. Mathewson MA, Ward SR, Chambers HG, Lieber RL. High resolution muscle measurements provide insights into equinus contractures in patients with cerebral palsy. J Orthop Res. (2015) 33:33–9. 10.1002/jor.22728
    1. Weide G, Huijing PA, Maas JC, Becher JG, Harlaar J, Jaspers RT. Medial gastrocnemius muscle growth during adolescence is mediated by increased fascicle diameter rather than by longitudinal fascicle growth. J Anat. (2015) 226:530–41. 10.1111/joa.12306
    1. Bénard MR, Harlaar J, Becher JG, Huijing PA, Jaspers RT. Effects of growth on geometry of gastrocnemius muscle in children: a three-dimensional ultrasound analysis. J Anat. (2011) 219:388–402. 10.1111/j.1469-7580.2011.01402.x
    1. Soo B, Howard JJ, Boyd RN, Reid SM, Lanigan A, Wolfe R, et al. . Hip displacement in cerebral palsy. J Bone Jt Surg Ser A. (2006) 88:121–9. 10.2106/00004623-200601000-00015
    1. Rehbein I, Teske V, Pagano I, Cúneo A, Pérez ME, von Heideken J. Analysis of orthopedic surgical procedures in children with cerebral palsy. World J Orthop. (2020) 11:222–31. 10.5312/wjo.v11.i4.222
    1. Stadskleiv K, Jahnsen R, Andersen GL, von Tetzchner S. Neuropsychological profiles of children with cerebral palsy. Dev Neurorehabil. (2018) 21:108–20. 10.1080/17518423.2017.1282054
    1. Stadskleiv K. Cognitive functioning in children with cerebral palsy. Dev Med Child Neurol. (2020) 62:283–9. 10.1111/dmcn.14463
    1. Handsfield GG, Meyer CH, Hart JM, Abel MF, Blemker SS. Relationships of 35 lower limb muscles to height and body mass quantified using MRI. J Biomech. (2014) 47:631–8. 10.1016/j.jbiomech.2013.12.002

Source: PubMed

3
Tilaa